Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A

Significance Microbes have the genetic capacity to produce large numbers of specialized compounds, yet produce only a small fraction of these in the laboratory. Here we introduce a genetic platform that allows the efficient production of natural product molecules from uncharacterized gene collections. We used transformation-associated recombination in yeast to directly clone and express an orphan biosynthetic gene cluster for the production of the lipopeptide antibiotic taromycin A. With this direct cloning approach, a single genomic capture and expression vector was designed directly from next-generation sequencing data, which precisely captures genetic loci of interest and readily facilitates genetic manipulations. This study highlights a “plug-and-play” approach to cryptic biosynthetic pathways for the discovery and development of natural product drug candidates. Recent developments in next-generation sequencing technologies have brought recognition of microbial genomes as a rich resource for novel natural product discovery. However, owing to the scarcity of efficient procedures to connect genes to molecules, only a small fraction of secondary metabolomes have been investigated to date. Transformation-associated recombination (TAR) cloning takes advantage of the natural in vivo homologous recombination of Saccharomyces cerevisiae to directly capture large genomic loci. Here we report a TAR-based genetic platform that allows us to directly clone, refactor, and heterologously express a silent biosynthetic pathway to yield a new antibiotic. With this method, which involves regulatory gene remodeling, we successfully expressed a 67-kb nonribosomal peptide synthetase biosynthetic gene cluster from the marine actinomycete Saccharomonospora sp. CNQ-490 and produced the dichlorinated lipopeptide antibiotic taromycin A in the model expression host Streptomyces coelicolor. The taromycin gene cluster (tar) is highly similar to the clinically approved antibiotic daptomycin from Streptomyces roseosporus, but has notable structural differences in three amino acid residues and the lipid side chain. With the activation of the tar gene cluster and production of taromycin A, this study highlights a unique “plug-and-play” approach to efficiently gaining access to orphan pathways that may open avenues for novel natural product discoveries and drug development.

[1]  C. Boddy,et al.  The role of transcription in heterologous expression of polyketides in bacterial hosts. , 2013, Natural product reports.

[2]  C. Bertelli,et al.  Rapid bacterial genome sequencing: methods and applications in clinical microbiology. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  H. Schweizer,et al.  An Improved Method for oriT-Directed Cloning and Functionalization of Large Bacterial Genomic Regions , 2013, Applied and Environmental Microbiology.

[4]  Kai Blin,et al.  antiSMASH 2.0—a versatile platform for genome mining of secondary metabolite producers , 2013, Nucleic Acids Res..

[5]  F. Stewart,et al.  Direct Cloning, Genetic Engineering, and Heterologous Expression of the Syringolin Biosynthetic Gene Cluster in E. coli through Red/ET Recombineering , 2012, Chembiochem : a European journal of chemical biology.

[6]  B. Moore,et al.  Flavoenzyme-catalyzed atropo-selective N,C-bipyrrole homocoupling in marinopyrrole biosynthesis. , 2012, Journal of the American Chemical Society.

[7]  Rolf Müller,et al.  Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting , 2012, Nature Biotechnology.

[8]  C. Hutchison,et al.  Cloning the Acholeplasma laidlawii PG-8A genome in Saccharomyces cerevisiae as a yeast centromeric plasmid. , 2012, ACS synthetic biology.

[9]  Anna Lechner,et al.  Selective overproduction of the proteasome inhibitor salinosporamide A via precursor pathway regulation. , 2011, Chemistry & biology.

[10]  H. Brückner,et al.  Use of Marfey's reagent and analogs for chiral amino acid analysis: assessment and applications to natural products and biological systems. , 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  S. Brady,et al.  Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolites , 2011, Proceedings of the National Academy of Sciences.

[12]  Christophe Corre,et al.  Identification of a bioactive 51-membered macrolide complex by activation of a silent polyketide synthase in Streptomyces ambofaciens , 2011, Proceedings of the National Academy of Sciences.

[13]  M. Bibb,et al.  Engineering Streptomyces coelicolor for heterologous expression of secondary metabolite gene clusters , 2011, Microbial biotechnology.

[14]  R. Breitling,et al.  Synthetic biology in Streptomyces bacteria. , 2011, Methods in enzymology.

[15]  S. Brady,et al.  Fluostatins produced by the heterologous expression of a TAR reassembled environmental DNA derived type II PKS gene cluster. , 2010, Journal of the American Chemical Society.

[16]  Paula Y. Calle,et al.  Cloning large natural product gene clusters from the environment: Piecing environmental DNA gene clusters back together with TAR , 2010, Biopolymers.

[17]  K. Maloney,et al.  Lodopyridone, a structurally unprecedented alkaloid from a marine actinomycete. , 2009, Organic letters.

[18]  Haruo Ikeda,et al.  Genomic basis for natural product biosynthetic diversity in the actinomycetes. , 2009, Natural product reports.

[19]  B. Gust.  Chapter 7. Cloning and analysis of natural product pathways. , 2009, Methods in enzymology.

[20]  Hanlee P. Ji,et al.  Next-generation DNA sequencing , 2008, Nature Biotechnology.

[21]  M. Berger,et al.  The Vibrio harveyi master quorum-sensing regulator, LuxR, a TetR-type protein is both an activator and a repressor: DNA recognition and binding specificity at target promoters , 2008, Molecular microbiology.

[22]  G. Challis.  Genome Mining for Novel Natural Product Discovery , 2008 .

[23]  L. Heide,et al.  Assembly and Heterologous Expression of the Coumermycin A1 Gene Cluster and Production of New Derivatives by Genetic Engineering , 2008, Chembiochem : a European journal of chemical biology.

[24]  Vladimir Larionov,et al.  Selective isolation of genomic loci from complex genomes by transformation-associated recombination cloning in the yeast Saccharomyces cerevisiae , 2008, Nature Protocols.

[25]  William Fenical,et al.  The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp. , 2008, Organic letters.

[26]  J. Micklefield,et al.  Stereospecific enzymatic transformation of alpha-ketoglutarate to (2S,3R)-3-methyl glutamate during acidic lipopeptide biosynthesis. , 2007, Journal of the American Chemical Society.

[27]  Corinna Lange,et al.  Genomics-driven discovery of PKS-NRPS hybrid metabolites from Aspergillus nidulans. , 2007, Nature chemical biology.

[28]  K. Nguyen,et al.  A glutamic acid 3‐methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus , 2006, Molecular microbiology.

[29]  Ben Shen,et al.  Microbial genomics for the improvement of natural product discovery. , 2006, Current opinion in microbiology.

[30]  Richard H. Baltz,et al.  Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? , 2006, Journal of Industrial Microbiology and Biotechnology.

[31]  J. Blanchard,et al.  The kinetic mechanism of AAC3-IV aminoglycoside acetyltransferase from Escherichia coli. , 2005, Biochemistry.

[32]  Rolf Müller,et al.  The impact of bacterial genomics on natural product research. , 2005, Angewandte Chemie.

[33]  Christopher J. Silva,et al.  Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. , 2005, Microbiology.

[34]  M. Bibb,et al.  Regulation of secondary metabolism in streptomycetes. , 2005, Current opinion in microbiology.

[35]  Rolf Müller,et al.  Heterologous expression of a myxobacterial natural products assembly line in pseudomonads via red/ET recombineering. , 2005, Chemistry & biology.

[36]  R. Hancock,et al.  Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. , 2004, Chemistry & biology.

[37]  Gregory L. Challis,et al.  Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Challis,et al.  PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Jason Micklefield,et al.  Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor. , 2002, Chemistry & biology.

[40]  M. Watve,et al.  How many antibiotics are produced by the genus Streptomyces? , 2001, Archives of Microbiology.

[41]  T. Kieser.  Practical streptomyces genetics , 2000 .

[42]  M. Fernández-Moreno,et al.  Characterization of the Pathway-Specific Positive Transcriptional Regulator for Actinorhodin Biosynthesis inStreptomyces coelicolor A3(2) as a DNA-Binding Protein , 1999, Journal of bacteriology.

[43]  J. Ishikawa,et al.  FramePlot: a new implementation of the frame analysis for predicting protein-coding regions in bacterial DNA with a high G + C content. , 1999, FEMS microbiology letters.

[44]  J. Barrett,et al.  Functional copies of a human gene can be directly isolated by transformation-associated recombination cloning with a small 3' end target sequence. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  E. Schmidt,et al.  Microsclerodermins C-E, antifungal cyclic peptides from the lithistid marine sponges Theonella sp. and Microscleroderma sp , 1998 .

[46]  F. Flett,et al.  High efficiency intergeneric conjugal transfer of plasmid DNA from Escherichia coli to methyl DNA-restricting streptomycetes. , 1997, FEMS microbiology letters.

[47]  M. Bibb,et al.  A novel family of proteins that regulates antibiotic production in streptomycetes appears to contain an OmpR‐like DNA‐binding fold , 1997, Molecular microbiology.

[48]  J. Barrett,et al.  Direct isolation of human BRCA2 gene by transformation-associated recombination in yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  K. Oldenburg,et al.  Recombination-mediated PCR-directed plasmid construction in vivo in yeast. , 1997, Nucleic acids research.

[50]  M. Bibb,et al.  afsR is a pleiotropic but conditionally required regulatory gene for antibiotic production in Streptomyces coelicolor A3(2) , 1996, Molecular microbiology.

[51]  R. Fleischmann,et al.  Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. , 1995, Science.

[52]  J. Kalinowski,et al.  Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. , 1994, Gene.

[53]  I. Kumagai,et al.  Effect of a rare leucine codon, TTA, on expression of a foreign gene in Streptomyces lividans. , 1993, Biochimica et biophysica acta.

[54]  S. Lin-Chao,et al.  High copy number of the pUC plasmid results from a Rom/Rop‐suppressible point mutation in RNA II , 1992, Molecular microbiology.

[55]  K. O'Brien,et al.  Plasmid cloning vectors for the conjugal transfer of DNA from Escherichia coli to Streptomyces spp. , 1992, Gene.

[56]  D. Macneil,et al.  Analysis of Streptomyces avermitilis genes required for avermectin biosynthesis utilizing a novel integration vector. , 1992, Gene.

[57]  R. Molloy,et al.  Enzymatic and chemical modifications of lipopeptide antibiotic A21978C: the synthesis and evaluation of daptomycin (LY146032). , 1988, The Journal of antibiotics.